Metabolic Therapy
In this video, Francisco Contreras spends about 25 minutes speaking on "Metabolic Therapy" at the 34th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Dr. Francisco Contreras
Dr. Francisco Contreras serves as director, president and chairman of the Oasis of Hope Hospital. A distinguished oncologist and surgeon, Contreras is renowned for combining conventional and alternative medical treatments with emotional and spiritual support to provide patients with the most positive treatment experience possible.
Oasis of Hope was founded by Contreras’ father, Dr. Ernesto Contreras, Sr. in 1963, and since then the hospital has provided integrative cancer treatment for more than 100,000 patients.
As director, Contreras continues the practice of his father’s two fundamental principles – do no harm and treat the patient as yourself. Today, Contreras oversees the treatment of 800 cancer patients annually.
After graduating with honors from medical school at the Autonomous University of Mexico in Toluca, Contreras studied alternative therapy at the Oasis of Hope Hospital. He then completed his specialty in surgical oncology at the University of Vienna in Austria, where he also graduated with honors.
Contreras has authored and co-authored several books concerning integrative therapy, cancer and heart disease prevention and chronic illness, including “The Hope of Living Cancer Free,” “The Hope of Living Long and Well,” “Fighting Cancer 20 Different Ways” and “Dismantling Cancer.” His newest book with co-author Daniel E. Kennedy, “Hope, Medicine & Healing,” is scheduled for release in fall 2008.
In addition to writing for numerous medical journals, Contreras has participated in medical conferences such as the World Conference on Breast Cancer and is active in the Cancer Control Society. He has been a part of governmental organizations, including the Georgia House of Representatives Health Policy Task Force and the Japanese Medical Association. He has also been on special assignment to Slovakia as a member of the Mexican Health Advisory Board.
A qualified entry-level professional motorcycle racer, Contreras says that racing is similar to performing surgery in that it requires 100 percent focus. Contreras and his wife, Rosa, have four daughters and one son. The family attends church in Bonita, Calif., and enjoys skiing and travel.
Transcription
Good afternoon.
I have quite a bit of information, so I want to get started. Yes. Can you hear me? Well. Last year I announced to you that we had applied permission to do a clinical trial at the Oasis Hospital, and we were granted a permission from the government to do a program called IMRT, which stands for integrated regulatory therapies where we are applying the use of foods that have tremendous power to change the metabolic pathway of cells, especially malignant cells, so that we could help patients that had no more hope in this protocol. I want to focus right now on our breast cancer patients, although the protocol is for other cancers as well. It's called the IRA to Breast Cancer Clinical Trial, which is prospective, randomized and controlled. What this means is that it complies with all of the rules that the book says in order to have a good study. It is not a double blind because we are a private entity and you can not do double blind studies in a private entity. But what happens is that you then compare your results against those of the literature. In this study, the criteria of inclusion had to be only patients in stage four that had failed to orthodox and alternative therapies, that his patients that came to us after failing to chemotherapy, radiation therapy and surgery. Then we treated those patients with alternatives and unfortunately had no results. The number of patients in this report, which is a preliminary report. I think we will be able to publish this by the end of this year or the beginning of next year. The length of the study to date is 18 months. The age of the patients is between 34 and sixty eight years of age. Let me show you one of our patients in during this hour. I will explain to you what what the therapy is like. This is a patient that came to us in May of 2005 with a very large recurrence on the side of the mastectomy.
This is what is called a C.T. scan. Then this is a PET scan and you see the tumor lighting up. And this is what is called a combination of pet C.T., a pet cat.
And so we're able to determine the size and location of the tumor very well. By September a year ago, the tumor had diminished very much. You can see here in by October, this patient was in complete remission. What is it that we do with the I.T.? We're able, due to new information that we have on how to manipulate the metabolism of the malignant cell